Full article view 2018-01-30T13:39:05+00:00
Back to News & Insights »

Precision's Experts Heading to Glasgow for ISPOR

 

Precision will be well represented at ISPOR’s 20th Annual European Congress, to be held November 4-8 at the Scottish Events Campus, Glasgow, Scotland.

In addition to the numerous Precision-led short courses, issue panels, podium presentations, breakout sessions, workshops and poster presentations, please be sure to stop by the convention floor and visit us in Booth #702 to learn more from our experts, as well as take a demo of our new interactive online evidence synthesis platform, Precision ESP.

For a complete list of our scientific presentations, please see below:

(Precision participants in bold)

SHORT COURSE:

Sunday, November 5th, 1:00pm – 4:00pm

Network Meta-Analysis in Relative Effectiveness Research

Presenters: Jansen JP, Kanters S

BREAKOUT SESSIONS (2):

Monday, November 6th, 3:30pm – 4:30pm

Adherence Patterns Among Patients Using Oral Atypical Antipsychotics and Other Medications

Presenters: Shafrin J, Lakdawalla DN, MacEwan JP, Silverstein AP, Hatch A, Forma F

Tuesday, November 7th, 8:45am – 9:45am

Does Valuation of Innovation in Appraisal of New Technologies Provide Appropriate Incentives for Manufacturers and Access for Patients?

Presenters: Claxton K, Maclean R, Greuger J, Sculpher M

ISSUE PANEL:

Monday, November 6th, 5:00pm – 6:00pm

“Mind the Gap!”: The Gap Between Regulatory and Reimbursement Evidence Requirements for Medical Devices

Moderator: Zema C

WORKSHOPS (2):

Monday, November 6th, 6:15pm – 7:15pm

Rare Disease Research, HTA and Evidence for Reimbursement

Presenters: Blanchette CM, Nestler-Parr S, Redekop K

Wednesday, November 8th, 10:00am – 11:00am

Disconnected or Limited Evidence in Network Meta-Analysis: What Can Be Done?

Presenters: Jansen JP, Thom H, Leahy J

PODIUM PRESENTATION:

Monday, November 6th, 2:15pm – 3:15pm

Multivariate Network Meta-Analysis of Survival Function Parameters

Presenters: Cope S, Chan K, Jansen JP

POSTERS (10):

Monday, November 6th, Author Hour: 12:45pm – 1:45pm

An Empirical Analysis of the Role of Learning By Doing in Dynamic Cost-Effectiveness

Authors: Incerti D, Peneva D, Shrestha A, Ramaswamy K, Smith G, Stevens W

Monday, November 6th, Author Hour: 12:45pm – 1:45pm

Systematic Literature Review and Indirect Treatment Comparision of the Efficacy of Semaglutide Versus Empagliflozin As Add-On To Basal Insulin

Authors: Kanters S, Wilkinson L, Lopes S, Popoff E, Jansen JP, Ploug UJ

Monday, November 6th, Author Hour: 12:45pm – 1:45pm

Assessing the Healthcare Cost of Diabetic Non-Small Cell Lung Cancer Patients Compared to Non-Small Cell Lung Cancer Patients

Authors: Ruban C, Blanchette CM, Howden R, Kowalkowski M, Marino J, Saunders WB

Monday, November 6th, Author Hour: 6:30pm – 7:30pm

Burden of Renal Transplant Among A Cohort of US Medicare Beneficiaries with Autosomal Dominant Polycystic Kidney Disease

Authors: Blanchette CM, Noone JM, Zenarosa G, Howden R

Monday, November 6th, Author Hour: 6:30pm – 7:30pm

Investigation of Demographic Differences for Non-Small Cell Lung Cancer Patients With and Without Type 2 Diabetes

Authors: Ruban C, Blanchette CM, Howden R, Kowalkowski M, Marino J, Saunders WB

Monday, November 6th, Author Hour: 6:30pm – 7:30pm

Emergency Department Use Among Autosomal Dominant Polycystic Kidney Disease Patients in the US

Authors: Blanchette CM, Noone JM, Zenarosa G, Howden R

Monday, November 6th, Author Hour: 6:30pm – 7:30pm

Assessing the Utilization of Diabetic Non-Small Cell Lung Cancer Patients Compared to Non-Small Cell Lung Cancer Patients

Authors: Ruban C, Blanchette CM, Howden R, Kowalkowski M, Marino J, Saunders WB

Tuesday, November 7th, Author Hour: 12:30pm – 1:30pm

Cost-Consequence of Use Fluciclovine (F 18) for the Diagnosis and Staging of Recurring Prostate Cancer

Authors: Jensen IS, Wu C, Cyr PL, Gauden D

Wednesday, November 8th, Author Hour: 12:45pm – 1:45pm

Exploring Structural Uncertainty With An Open-Source Cost-Effectiveness Model for Rheumatoid Arthritis

Authors: Incerti D, Curtis JR, Lorenzi M, Jansen JP

Wednesday, November 8th, Author Hour: 12:45pm – 1:45pm

Parametric Modelling of Migrane Day Frequency in Migrane Prevention: A Case Study of Erenumab Clinical Trial Data

Authors: Porter JK, Di Tanna GL, Villa G, Brennan A, Palmer S, Lipton RB, Jansen JP, Shah N, Desai P, Sapra S

Wednesday, November 8th, Author Hour: 12:45pm – 1:45pm

Novel Biologics Versus Conventional Preventive Therapies in Migrane: A Framework for Economic Evaluation

Authors: Lipton RB, Brennan A, Palmer S, Jansen JP, Hatswell AJ, Porter JK, Di Tanna GL, Villa G, Shah N, Sapra S

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.